Your browser doesn't support javascript.
loading
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.
Coyle, Peter V; Chemaitelly, Hiam; Ben Hadj Kacem, Mohamed Ali; Abdulla Al Molawi, Naema Hassan; El Kahlout, Reham Awni; Gilliani, Imtiaz; Younes, Nourah; Al Anssari, Ghada Ali A A; Al Kanaani, Zaina; Al Khal, Abdullatif; Al Kuwari, Einas; Butt, Adeel A; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Abdul Rahim, Hanan F; Nasrallah, Gheyath K; Yassine, Hadi M; Al Kuwari, Mohamed Ghaith; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H; Bertollini, Roberto; Abu-Raddad, Laith J.
Afiliación
  • Coyle PV; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Chemaitelly H; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.
  • Ben Hadj Kacem MA; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, BT7 1NN United Kingdom.
  • Abdulla Al Molawi NH; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.
  • El Kahlout RA; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, P.O. Box 24144, Qatar.
  • Gilliani I; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Younes N; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Anssari GAAA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Kanaani Z; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Khal A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Kuwari E; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Butt AA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Shaik RM; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.
  • Abdul Rahim HF; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Nasrallah GK; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Yassine HM; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Kuwari MG; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.
  • Al Romaihi HE; College of Health Sciences, QU Health, Qatar University, Doha, P.O. Box 2713, Qatar.
  • Al-Thani MH; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.
  • Bertollini R; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, P.O. Box 2713, Qatar.
  • Abu-Raddad LJ; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.
iScience ; 24(6): 102646, 2021 Jun 25.
Article en En | MEDLINE | ID: mdl-34056566
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2021 Tipo del documento: Article País de afiliación: Qatar Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2021 Tipo del documento: Article País de afiliación: Qatar Pais de publicación: Estados Unidos